Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock

Edwards Lifesciences (EW) remains Canaccord's top pick in the medical technology sector, as the firm sees a number of catalysts for the companies in the sector when they report earnings over the next few weeks, but the firm is most positive on Edwards.

Canaccord expects commentary regarding Boston Scientific's (BSX) Lotus value to be positive for Edwards Lifesciences, and expects positive updates on EW's transcatheter mitral/ tricuspid technologies.

Edwards' stock was up slightly in early Monday afternoon trading.

(What will move markets this quarter and how should investors position themselves ahead of time? Jim Cramer sat down with four of TheStreet's top columnists recently to get their views. Click here to listen to his latest Trading Strategies roundtable with them and read their advice for stocks, bonds, forex and gold.)

If you liked this article you might like

Edwards Lifesciences: Cramer's Top Takeaways

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Edwards Lifesciences Is Not Skipping A Beat